share_log

Vertex Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Sachdev Amit

SEC announcement ·  Feb 27 17:02
Summary by Moomoo AI
Vertex Pharmaceuticals EVP, Amit Sachdev, completed the sale of 5,473 shares of common stock between February 23, 2024, and February 26, 2024. The transactions were executed at prices ranging from $425.70 to $431.79, resulting in a total market value of $2,344,892.31. Following these transactions, Sachdev directly holds 55,325 shares. Additionally, Sachdev has an indirect ownership of 7,447 shares, which includes 882 shares in a 401(k) and 6,565 shares held in trust.
Vertex Pharmaceuticals EVP, Amit Sachdev, completed the sale of 5,473 shares of common stock between February 23, 2024, and February 26, 2024. The transactions were executed at prices ranging from $425.70 to $431.79, resulting in a total market value of $2,344,892.31. Following these transactions, Sachdev directly holds 55,325 shares. Additionally, Sachdev has an indirect ownership of 7,447 shares, which includes 882 shares in a 401(k) and 6,565 shares held in trust.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more